Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance

NCT03880058 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Scars

Interventions

DRUG: SLI-F06
DRUG: Formulation buffer

Sponsor

Scarless Laboratories, Inc.

Collaborators

[object Object]